Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2026-05-17 @ 12:37 PM
Study NCT ID:
NCT05928468
Status:
UNKNOWN
Last Update Posted:
2023-07-03
First Post:
2023-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002
Sponsor:
Guangzhou Patronus Biotech Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LYB002/CT-CHN-IIT02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None